EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney Injury

Daniel Fernández-Llaneza iD, Romy M P Vos iD, Joris E Lieverse iD, Helen R Gosselt iD, Sandra L Kane-Gill iD, Teun van Gelder iD, Joanna E Klopotowska iD, LEAPfROG Consortium

Drug Safety · 2025

DOI: 10.1007/s40264-024-01474-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, 2025. Verfasst von Daniel Fernández-Llaneza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Informatics, Amsterdam University Medical Centre, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVE: The recent rise in acute kidney injury (AKI) incidence, with approximately 30% attributed to potentially preventable adverse drug events (ADEs), poses challenges in evaluating drug-induced AKI due to polypharmacy and other risk factors. This study seeks to consolidate knowledge on the drugs with AKI potential from four distinct sources: (i) bio(medical) peer-reviewed journals; (ii) spontaneous reporting systems (SRS); (iii) drug information databases (DIDs); and (iv) NephroTox website. By harnessing the potential of these underutilised sources, our objective is to bridge gaps and enhance the understanding of drug-induced AKI. METHODS: By searching Medline, studies with lists of drugs with AKI potential established through consensus amongst medical experts were selected. A final list of 63 drugs was generated aggregating the original studies. For these 63 drugs, the AKI reporting odds ratios (RORs) using three SRS databases, the average frequency of ADEs from four different DIDs and the number of published studies identified via NephroTox was reported. RESULTS: Drugs belonging to the antivirals, antibacterials, and non-steroidal anti-inflammatory pharmacological classes exhibit substantial consensus on AKI potential, which was also reflected in strong ROR signals, frequent to very frequent AKI-related ADEs and a high number of published studies reporting adverse kidney events as identified via NephroTox. Renin-angiotensin aldosterone system inhibitors and diuretics also display comparable signal strengths, but this can be attributed to expected haemodynamic changes. More variability is noted for proton-pump inhibitors. CONCLUSIONS: By integrating four disjointed sources of knowledge, we have created a novel, comprehensive resource on drugs with AKI potential, contributing to kidney safety improvement efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryDrug-Related Side Effects and Adverse ReactionsHumansAdverse Drug Reaction Reporting SystemsDatabases, FactualRisk Factors

Autor:innen und Institutionen

  • Department of Medical Informatics, Amsterdam University Medical Centre, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands. d.fernandezllaneza@amsterdamumc.nl.
  • Amsterdam Public Health Institute, Digital Health, Amsterdam, The Netherlands. d.fernandezllaneza@amsterdamumc.nl.
  • Amsterdam Public Health Institute, Methodology, Amsterdam, The Netherlands. d.fernandezllaneza@amsterdamumc.nl.
  • Department of Computer Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Department of Medical Informatics, Amsterdam University Medical Centre, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.
  • Amsterdam Public Health Institute, Digital Health, Amsterdam, The Netherlands.

ORCID-Profile: Daniel Fernández-Llaneza, Romy M P Vos, Joris E Lieverse, Helen R Gosselt, Sandra L Kane-Gill, Teun van Gelder, Joanna E Klopotowska

Förderung

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Fernández-Llaneza, D., Vos, R. M. P., Lieverse, J. E., Gosselt, H. R., Kane-Gill, S. L., van Gelder, T., Klopotowska, J. E., & LEAPfROG Consortium (2025). An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney Injury. Drug Safety. https://doi.org/10.1007/s40264-024-01474-w

Vancouver

Fernández-Llaneza D, Vos RMP, Lieverse JE, Gosselt HR, Kane-Gill SL, van Gelder T, et al. An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney Injury. Drug Safety. 2025. doi:10.1007/s40264-024-01474-w

BibTeX
@article{FernndezLlaneza2025,
  author = {Fernández-Llaneza, Daniel and Vos, Romy M P and Lieverse, Joris E and Gosselt, Helen R and Kane-Gill, Sandra L and van Gelder, Teun and Klopotowska, Joanna E and LEAPfROG Consortium, LEAPfROG Consortium},
  title = {An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney Injury},
  journal = {Drug Safety},
  year = {2025},
  doi = {10.1007/s40264-024-01474-w}
}
Kostenlos starten →